Accéder au contenu
Merck

Identification of a nuclear receptor that is activated by farnesol metabolites.

Cell (1995-06-02)
B M Forman, E Goode, J Chen, A E Oro, D J Bradley, T Perlmann, D J Noonan, L T Burka, T McMorris, W W Lamph, R M Evans, C Weinberger
RÉSUMÉ

Nuclear hormone receptors comprise a superfamily of ligand-modulated transcription factors that mediate the transcriptional activities of steroids, retinoids, and thyroid hormones. A growing number of related proteins have been identified that possess the structural features of hormone receptors, but that lack known ligands. Known as orphan receptors, these proteins represent targets for novel signaling molecules. We have isolated a mammalian orphan receptor that forms a heterodimeric complex with the retinoid X receptor. A screen of candidate ligands identified farnesol and related metabolites as effective activators of this complex. Farnesol metabolites are generated intracellularly and are required for the synthesis of cholesterol, bile acids, steroids, retinoids, and farnesylated proteins. Intermediary metabolites have been recognized as transcriptional regulators in bacteria and yeast. Our results now suggest that metabolite-controlled intracellular signaling systems are utilized by higher organisms.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Farnesol, 95%
Sigma-Aldrich
Farnesol, mixture of isomers, ≥95%, stabilized, FG
Sigma-Aldrich
FXR (Farnesoid-X-activated receptor) human, recombinant, expressed in E. coli, ≥80% (SDS-PAGE)
Sigma-Aldrich
FXR, GST tagged human, recombinant, expressed in E. coli, ≥70% (SDS-PAGE)
Sigma-Aldrich
FXR-ligand binding domain (222-472) human, recombinant, expressed in E. coli, ≥80% (SDS-PAGE)
Sigma-Aldrich
FXR, ligand binding domain (222-472), GST tagged human, recombinant, expressed in E. coli, ≥70% (SDS-PAGE)